These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33220816)

  • 1. [Male non-neurogenic overactive bladder].
    Phé V; Gamé X
    Prog Urol; 2020 Nov; 30(14):880-886. PubMed ID: 33220816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery].
    de la Taille A; Robert G; Descazeaud A
    Prog Urol; 2018 Nov; 28(15):813-820. PubMed ID: 30262261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of non-neurogenic overactive bladder syndrome].
    Phé V; Gamé X
    Prog Urol; 2020 Nov; 30(14):895-903. PubMed ID: 33220818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-neurological overactive bladder and pelvic-perineal pathology in women].
    Gamé X; Phé V
    Prog Urol; 2020 Nov; 30(14):887-894. PubMed ID: 33220817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can prostate stents be used to predict the outcome of transurethral resection of the prostate in the difficult cases?
    Knutson T
    Curr Opin Urol; 2004 Jan; 14(1):35-9. PubMed ID: 15091048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI-RS 2023.
    Tarcan T; Hashim H; Malde S; Sinha S; Sahai A; Acar O; Selai C; Agro EF; Abrams P; Wein A
    Neurourol Urodyn; 2024 Aug; 43(6):1447-1457. PubMed ID: 38477358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there concordance between overactive bladder and detrusor overactivity in men with predominant storage urinary symptoms referred to Functional Urology and Urodynamics Units?
    Esteban-Fuertes M; Prieto-Chaparro L; Arlandis-Guzmán S; Salinas-Casado J; Gago-Ramos JL;
    Actas Urol Esp (Engl Ed); 2022; 46(1):41-48. PubMed ID: 34848162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Definition, epidemiology and impact of non-neurogenic overactive bladder].
    Phé V; Gamé X
    Prog Urol; 2020 Nov; 30(14):866-872. PubMed ID: 33220814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
    Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overactive bladder in men: special considerations for evaluation and management.
    Dmochowski RR; Staskin D
    Urology; 2002 Nov; 60(5 Suppl 1):56-62; discussion 62-3. PubMed ID: 12493356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent detrusor overactivity after transurethral resection of the prostate.
    Housami F; Abrams P
    Curr Urol Rep; 2008 Jul; 9(4):284-90. PubMed ID: 18765127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitive or Detrusor Overactivity: Which is Associated with Filling Symptoms in Female Bladder Outlet Obstructed Patients.
    Zhang J; Cao M; Chen Y; Liang W; Liang Y
    Urol J; 2019 Jun; 16(3):285-288. PubMed ID: 30882167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
    Chughtai B; Dunphy C; Lee R; Lee D; Sheth S; Marks L; Kaplan SA; Te AE
    Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of urodynamic preoperative detrusor overactivity on the outcomes of transurethral surgery in patients with male bladder outlet obstruction: a systematic review and meta-analysis.
    Kim M; Jeong CW; Oh SJ
    World J Urol; 2019 Mar; 37(3):529-538. PubMed ID: 30006907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
    Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of intravesical prostatic protrusion in the evaluation of overactive bladder in male patients with LUTS.
    Tsai CH; Lee WC; Shen YC; Wang HJ; Chuang YC
    Int Urol Nephrol; 2020 May; 52(5):815-820. PubMed ID: 31897874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.